Update of the CLRP TG-43 parameter database for low-energy brachytherapy
  sources by Safigholi, Habib et al.
Update of the CLRP TG-43 parameter database for
low-energy brachytherapy sources
Habib Safigholi, Marc J. P. Chamberlanda), Randle E. P. Taylorb), Christian H. Allen,
Martin P. Martinov, D. W. O. Rogers, and Rowan M. Thomson
Carleton Laboratory for Radiotherapy Physics (CLRP), Department of Physics,
Carleton University, Ottawa, Ontario, K1S 5B6, Canada
a) Present address, Medical Physics, The University of Vermont Medical Center, Burlington,
Vermont, 05401, USA
b) Present address, Multi Leaf Consulting, Port Elgin, ON, Canada, N0H 2C3
Abstract
Purpose: To update the Carleton Laboratory for Radiotherapy Physics (CLRP)
TG-43 dosimetry database for low-energy (≤ 50 keV) photon-emitting low-dose rate
(LDR) brachytherapy sources utilizing the open-source EGSnrc application egs brachy
rather than the BrachyDose application used previously for 27 LDR sources in the
2008 CLRP version (CLRPv1). CLRPv2 covers 40 sources (103Pd, 125I, and 131Cs).
A comprehensive set of TG-43 parameters is calculated, including dose-rate constants,
radial dose functions with functional fitting parameters, 1D and 2D anisotropy func-
tions, along-away dose-rate tables, Primary-Scatter separation dose tables (for some
sources), and mean photon energies at the surface of the sources. The database also
documents the source models which will become part of the egs brachy distribution.
Acquisition and Validation Methods: Datasets are calculated after a system-
atic recoding of the source geometries using the egs++ geometry package and its
egs brachy extensions. Air-kerma strength per history is calculated for models of
NIST’s Wide-Angle Free-Air chamber (WAFAC) and for a point detector located at
10 cm on the source’s transverse axis. Full scatter water phantoms with varying
voxel resolutions in cylindrical coordinates are used for dose calculations. New sta-
tistical uncertainties of source volume corrections for phantom voxels which overlap
with brachytherapy sources are implemented in egs brachy, and all CLRPv2 data
include these uncertainties. For validation, data are compared to CLRPv1 and other
data in the literature.
Data Format and Access: Data are available at https://physics.carleton.ca/
clrp/egs_brachy/seed_database_v2. As well as being presented graphically in com-
parisons to previous calculations, data are available in Excel (.xlsx) spreadsheets for
each source.
Potential Applications: The database has applications in research, dosimetry, and
brachytherapy planning. This comprehensive update provides the medical physics
community with more accurate TG-43 dose evaluation parameters, as well as fully-
benchmarked and described source models which are distributed with egs brachy.
Key words: Low-energy brachytherapy, CLRP, TG-43, database, EGSnrc, Monte Carlo
egs brachy
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I. Introduction
The TG-43 protocol1 presented a worldwide standard dosimetry formalism for brachytherapy
sources and has led to an estimated 5% uncertainty on brachytherapy dosimetry.2 Presently,
brachytherapy dosimetry and planning is widely based on the single source consensus data
published in reports: TG-43 (1995),1 the 2004 update (TG-43U1),3,4 the supplements in
2007 (TG-43U1S1)5 and 2017 (TG-43U1S2),6,7 and the AAPM/ESTRO TG-152 report for
High-Energy Brachytherapy source Dosimetry (HEBD).8 Monte Carlo (MC) calculations are
the predominant method of determining consensus values for the radial dose function, g(r),
and the 2D anisotropy function, F (r, θ), for both low- and high-energy sources. Consensus
dose-rate constants (DRCs or Λ) for low-energy sources are currently taken as averages of
the mean of MC calculations and the mean of measurements since historically there was a
systematic difference between the two (see ref9 for a summary). In contrast, consensus DRCs
for high-energy sources are based solely on MC calculations.8
In 2008, version 1 of the Carleton Laboratory for Radiotherapy Physics TG-43
database (CLRPv1) was published.10–12 It was compiled using the EGSnrc MC applica-
tion BrachyDose and contains DRCs, g(r), and F (r, θ) values for 42 low- and high-energy
brachytherapy sources. These data were extensively used in the TG-43U1S2 report.6,7 Since
the 2008 CLRPv1 version of the TG-43 database, several low- and high-energy photon-
emitting brachytherapy sources have become available and are on the AAPM/IROC Hous-
ton Registry of Brachytherapy Sources (http://rpc.mdanderson.org/rpc/). Also, various
minor errors in modelling the source geometries and in MC simulations reported in CLRPv1
have been uncovered. Furthermore, a fast, versatile, and open source EGSnrc application,
called egs brachy, was developed within the CLRP13 and recently released as open-source
software.14
The goal of the present work is to perform a comprehensive update of the CLRPv1 TG-
43 database parameters for low-energy, low-dose rate (LDR) brachytherapy sources with a
single consistent approach using egs brachy. This “CLRPv2” update includes an indepen-
dent recalculation of the datasets with more precision and is based on the egs++ package
(Kawrakow et al., 201815) with some extensions created for the egs brachy application.13
The CLRPv2 dataset includes a total of 40 low-energy sources for radionuclides 103Pd, 125I,
and 131Cs; higher energy brachytherapy sources will be added in future work. Some of these
sources are no longer in production; however, they are included to provide dosimetry param-
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eters for retrospective analyses and research. The brachytherapy source geometry models
described and benchmarked by the comparisons in the CLRPv2 database will be released
for use with the open source egs brachy application.
II. Acquisition and Validation Methods
II.A. Computational tools and Monte Carlo simulations
All calculations are performed with the EGSnrc application egs brachy13 (GitHub commit
hash 4f3ecac version with additions regarding the statistical uncertainties in the volume
corrections described below). This is free and open-source software for doing rapid MC
brachytherapy dose calculations available via https://physics.carleton.ca/clrp/egs_
brachy/. Electron transport, although available in egs brachy, is not modelled in the cur-
rent calculations. The photon cutoff energy is set to 1 keV, except for air-kerma strength
calculations for which the photon cutoff energy is 5 keV to eliminate the characteristic x
rays from Ti as required by the definition.3 Rayleigh scattering, bound Compton scattering,
photoelectric absorption, and fluorescent emission of characteristic x rays are all simulated.
Photon cross sections are taken from the XCOM database16 and mass energy absorption
coefficients are calculated with the application g as distributed with the EGSnrc package
before 2017. Recent improvements17 in the EGSnrc code and the application g mean that
these mass energy absorption coefficient values would change by up to a maximum of 0.2%
using the newer releases of EGSnrc. There is ambiguity in whether renormalized or un-
renormalized Scofield photoelectric cross sections are in better agreement with experimental
data;18 the current work employs the unrenormalized cross sections (consistent with EGSnrc
default15). Initial photon energies and probabilities are sampled from the NNDC19 spectra
for 103Pd, and 131Cs sources. For 125I, the photon spectrum from the NCRP Report 5820
is used since Rodriguez and Rogers21 demonstrated that using the NCRP spectrum leads
to better agreement with measured spectra for many seeds and it is consistent with the
spectrum recommended by the BIPM for use by primary standards labs.22
Dose calculations are done in a full scattering cylindrical water phantom (30 cm long,
15 cm radius). In addition, for three representative sources, a larger water phantom is
modelled (40 cm long, 20 cm radius). For efficiency purposes, collision kerma and hence
absorbed dose is scored in concentric cylindrical shells, as sources are cylindrically symmetric
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and there is charged particle equilibrium for low-energy brachytherapy sources. As discussed
previously,23 to increase accuracy and reduce bin size artifacts, the radial (r) and length (z)
resolutions of the cylindrical shells are 0.1 mm for r ≤ 1 cm, 0.5 mm for 1 cm < r ≤ 5 cm,
1 mm for 5 cm < r ≤ 10 cm and 2 mm for r > 10 cm where r is the radial distance from the
cylinder’s axis (and source is aligned along the z-axis). All calculations employ egs brachy’s
tracklength scoring of collision kerma.
Air-kerma strength per history, ShistK , is scored in vacuo, using a scoring voxel located
on the transverse axis 10 cm away from the source and of size 0.1×0.1×0.05 cm3 when
approximating a point detector, or 2.66×2.66×0.05 cm3 when representing the solid angle
subtended by the primary collimator of the NIST WAFAC24 detector. The two voxel sizes
are referred to as ‘Point’ and ‘WAFAC’ detectors, respectively, on the CLRP TG-43 website.
In both cases, corrections are made to determine the air-kerma on the axis at the front of
the detector using the same kr2 correction factors as used for CLRPv1.
23 The factors used
are 1.0050 and 1.0168 for the point and WAFAC detectors respectively. Strictly speaking,
the formula for these correction factors has been shown to be wrong in general.25 However,
for the geometries of the detectors used here, they have been shown to be highly accurate.25
For most LDR sources, the point and WAFAC estimates of the air-kerma strength are
the same. However for some low-energy sources in which the radioactivity is deposited on
high-Z radio-opaque surfaces with sharp corners, the on-axis point estimate is lower because
the high-Z materials attenuate photons from the end surfaces aimed on the axis.26 This
leads to a well-known dependence on the scoring voxel size when determining the air-kerma
strength23 and hence the dose-rate constant. The geometry of the detector’s sensitive region
for air-kerma calculations is filled with a very low-density dry air, as recommend by TG-43.
Enough histories (∼ 5 × 1010) are simulated to ensure that g(r), and F (r, θ) results
have a k=1 statistical uncertainty ≤ 0.05% at r ≤ 5 cm, and DRC results have statistical
uncertainties ≤0.2% for point detectors or ≤0.02% for WAFAC detectors.
II.A.1. Dealing with long sources
The kr2 corrections required to convert the average kerma in the WAFAC detector’s volume
or front surface to the kerma on the axis as required for determining the air-kerma strength
are usually derived analytically assuming that the source is an on-axis isotropically radiating
point source. However, these assumptions break down for the long CivaTech sources. Paxton
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et al27 showed that the NIST WAFAC cannot, in principle, directly measure the air-kerma
strength for long sources because some photons would create charge outside the charge-
collecting region. This issue does not affect the University of Wisconsin’s (UW’s) variable-
aperture free-air chamber (VAFAC).27 However, that still leaves the issue of determining
the kr2 corrections for non-point sources. We have done that by calculating the average air
kerma per history in a thin (0.001 cm thick) circular detector (radius 1.333 cm) at 10 cm
from the axis for a series of point sources off-axis and comparing that average to the air
kerma per history in a small on-axis voxel (0.1× 0.1× 0.001 cm3). The detector subtended
the same solid angle as the NIST WAFAC or UW VAFAC detectors at 30 cm. The values
of kr2 for line sources is then determined by integrating the corrections as a function of the
point source’s distance off-axis. The values varied from 1.0094 for a point source to 1.0084 for
a 5 cm line source. These values agree within 0.05% with those calculated by Paxton et al27
of 1.0089 to 1.0087 for the same range of source lengths. The point source on axis compares
well with the analytic value for detectors of the same area of 1.0094 (square detector) or
1.0090 (circular detector).25 On the assumption that there should be no difference in the
air-kerma strength based on the WAFAC geometry or the point-source geometry, the ratio of
the point to WAFAC geometry raw calculations for the CivaTech sources can also be used to
estimate kr2 factors; on average, they agree within (0.02± 0.02)% with the values calculated
based on integration of the point-source calculations.
II.B. Source Volume Correction
It was observed that dose values in voxels overlapping a source were affected by the sometimes
large statistical variations in the source volume corrections which correct the voxel volume
to account for this overlap. Thus, the statistical uncertainty on the source volume correction
needs to be quantified and minimized for those phantom voxels which contain part of the
source. The source volume correction calculations in egs brachy are performed with a MC
calculation in one of two source boundary shapes (cylinder or box) around a brachytherapy
source. Random points within the boundary shape are generated with a specified random
point density (cm−3). The number of points which fall inside both the source and the voxel
of interest are tallied and also the total number within the boundary shape is known. The
ratio of these two counts, i.e., the fraction of the volume of the bounding shape occupied by
the source within the voxel of interest, is used to determine the source volume correction.
The density of random points is specified in the input to egs brachy and a range from 103
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to 1012 cm−3 can be relevant. Figure 1 shows a typical source which overlaps 4 phantom
voxels and is surrounded by a boundary shape (dashed line).
V0 - VS 
NS, VS 
Nb, Vb 
Figure 1: A schematic diagram of a source volume correction calculation in
egs brachy. Volume Vs (hatched region) is the part of the source volume that is
unknown and is needed for volume correction to the voxel with uncorrected volume
V0. The source boundary shape (red dashes) has volume Vb around the source with Nb
random points generated within the region. The number of random points which fall
in both the source and voxel of interest, i.e., Vs, is Ns.
For each voxel overlapping the source, egs brachy calculates the volume Vs by tracking
Ns, the number of random points generated in Vb that fall in the source region and within
the voxel under consideration. Since the total boundary volume Vb and the total number of
points generated by egs brachy within the source boundary volume, Nb are known, then
the source volume, Vs, is calculated as:
Vs = Vb · Ns
Nb
=
Ns
PD
, (1)
where Nb = PD ·Vb with PD (cm−3) being the density of random points used. The corrected
volume (Vcorr) is then calculated as:
Vcorr = V0 − Vs = V0 − Vb · Ns
Nb
. (2)
As the nature of MC target finding is binary (i.e., a point generated in Vb is either in Vs
or not), it can be represented by a discrete Bernoulli distribution.28 Therefore, if the mean
fraction is Ns/Nb, the standard deviation of the mean would be
sNs
Nb
=
√
Ns
Nb
(1− Ns
Nb
)√
Nb
=
√√√√Ns(Nb −Ns)
N3b
. (3)
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Using the error propagation law on the relationship between Vcorr and Ns/Nb in equa-
tion (2), the final fractional uncertainty on Vcorr can be written as:
∣∣∣∣sVcorrVcorr
∣∣∣∣ = VbV0 − Vs
√√√√Ns(Nb −Ns)
N3b
=
1
(PD V0 −Ns)
√
Ns(Nb −Ns)
Nb
. (4)
or writing in terms of the volumes involved by using Ns = VsPD and Nb = VbPD:
∣∣∣∣sVcorrVcorr
∣∣∣∣ = 1PD(V0 − Vs)
√
PD Vs(PD Vb − PD Vs)
PD Vb
=
1√
PD
√√√√ Vs( Vb − Vs)
Vb(V0 − Vs)2 =
k√
PD
, (5)
where k is a constant depending only on V0, Vb and Vs.
If a source volume correction is needed, its statistical uncertainty can play an important
role and must be included in the statistical uncertainty on the voxel’s dose. Therefore, source
volume correction uncertainties have been implemented in egs brachy for voxels containing
all or part of a source. The random point density,PD, is a user input.
Figure 2a presents the source volume correction, Fcorr = (V0 − Vs)/V0, as a function
of different point densities (103 − 1012 cm−3) after the above statistics are implemented in
egs brachy for a specific region very close to a 6711 source (r = 0.1 cm, z = 0.09 cm).
These values are compared to the analytic volume correction. The error bars are statistical
uncertainties generated by egs brachy. When the point density is very low (103− 104 cm−3
with a seed volume of roughly 4×10−3 cm3), it is possible that no random points fall in Vs
(i.e., Ns=0) and hence no volume correction is made. When the point density is increased
(105 − 107 cm−3), random points are generated in both parts of the voxel. As point density
continues to increase, the code eventually calculates the correct phantom volume compared
to the analytic calculation for a point density of 1010 (1011) within 0.2% (0.08%) where the
calculated uncertainty is 0.5% (0.09%).
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Figure 2: (a) Calculated volume correction (Fcorr=(V0 − Vs)/V0) compared to the
analytic volume correction as a function of different point densities for a region very
close to a source (125I model 6711). (b) Calculated average source volume correction
uncertainty for all voxels which overlap the source (with 98% threshold coverage) as
a function of point density. (c) TG-43 anisotropy function calculated with 106 and
108 cm−3 point densities with uncertainties calculated with egs brachy. Less than 1%
of the voxels require a source volume correction for this calculation.
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Figure 2b shows, as a function of point density, the average uncertainty on the volume
correction for all voxels which overlap with a typical brachytherapy source (125I model 6711),
have doses >0 (i.e., are not completely covered by the source), and have more than 2% of
the voxel volume outside of the source. This last condition is to avoid the very occasional
extreme fluctuation in uncertainty for these very small regions outside the source. As the
point density is increased, the dose uncertainties decrease proportional to 1/
√
PD as seen
in equation 5.
Figure 2c presents the calculated TG-43 anisotropy function for two different point den-
sities (106 vs 108). Values are the same for cases in which volume corrections are not needed,
but differ (albeit within statistical uncertainties) for regions close to the source (e.g., r=
0.1 cm, z = 0.09 cm or θ = 25◦), where the voxel overlaps with the source. Such large
differences explain why there are often large differences outside statistics between CLRPv1
(BrachyDose) and CLRPv2 (egs brachy) results for voxels overlapping the source since the
CLRPv1 data did not include the uncertainties on the volume correction. Fortunately, since
the CLRPv1 data were only wrong in very high-dose regions or very small regions close to
the source, they would have no practical effects on clinical dose evaluations using these data.
When the point density is increased 10 times (e.g., from 108 to 109), the volume correction
calculation time increases approximately tenfold (e.g., from 0.09 to 0.93 sec for a single seed
case). For the database calculations a point density of 1010 cm−3 was used which implies
sub-1% average uncertainty on the volume corrections for voxels overlapping the sources.
II.C. TG-43 dosimetry parameters calculations
Following the 1995 TG-43 protocol,1,3 the 2D dose-rate distribution around a sealed
brachytherapy source is determined as:
D˙(r, θ) = SK · Λ · GL(r, θ)
GL(r0, θ0)
· gL(r) · F (r, θ), (6)
where r is the distance from the center of the source’s radioactivity to the point of interest,
r0 is the reference point which is defined at (1 cm, 90
◦) on the transverse source axis, and
θ denotes the polar angle determining the point of interest. Other quantities and functions
are defined elsewhere in this paper, and are discussed in more detail in the TG-43 reports.
TG-43 dosimetry parameters are calculated for 40 low-energy LDR photon-emitting
brachytherapy sources. The 13 sources added to the CLRPv2 database are shown in Figure 3.
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A detailed description of all 40 sources is available online in the database.
a). 103Pd (CS10  and CT10) CivaTech b). 125I (I25.S18) BEBIG
e). 103Pd (CS20 and CT20) CivaTech
h). 103Pd (CS40 and CT40) CivaTech
i). 103Pd (CS50 and CT50) CivaTech
c). 125I (I25.S17plus) BEBIG d). 125I (9011) Amersham
g). 131Cs (CS-1 Rev-2) IsoRayf). 125I (AgX100) Theragenics
Figure 3: Low-energy, LDR photon-emitting brachytherapy sources added to CLRPv2.
Source geometries are displayed using the egs view visualization tool of egs++. A
consistent color coding format for different materials is used throughout the database.
Source dimensions are not to scale from one source to the next, but are to scale for
each source.
Each source is modelled using the egs++ class library15 geometry module. The egs++
geometry models of all sources will be distributed freely with egs brachy. For each source,
the results of three 3D MC dose calculations in full-scatter water phantoms with different
voxel resolutions (0.1, 0.5, and 1 mm3) and the results of two MC simulations of air-kerma
strength measurements (Point and WAFAC detectors) are imported into an in-house Python
software tool, which extracts all TG-43 data. The same Python suite was used to produce the
CLRPv1 database.10,11 Dose values are tabulated as a function of distance from the source
and polar angle relative to the long (Z) axis of the source. Dose values are interpolated
bilinearly using the nearest neighboring voxels when the point of interest does not fall at the
center of a voxel. The database specifies the effective active length of each source, Leff , which
accounts for the effect of the physical shape of the radioactive material distribution inside
the source. It is calculated using the TG-43U1 effective line source length approximation,3,29
and in some complicated cases (e.g.,103Pd Best Medical model 2335) the maximum distance
between proximal and distal aspects of the radioactivity distribution is used.29
The radial dose function, g(r), is calculated using point (GP (r, θ)), and line (GL(r, θ))
source geometry functions, and is tabulated at intervals of 0.01 cm for 0.05 ≤ r ≤ 0.1 cm,
0.1 cm for 0.1 < r ≤ 1.0 cm, and 0.5 cm for 5 < r ≤ 10 cm. Values at r = 0.15, 0.25,
and 0.75 cm are also reported. Fitting coefficients for the following fifth-order polynomial
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functional form for gL(r) as proposed by Taylor and Rogers
30 are also calculated.
gL(r) =
(
a0r
−2 + a1r−1 + a2 + a3r + a4r2 + a5r3
)
e−a6r. (7)
For each source’s g(r), the mean residual deviations from the actual data for the best fit
functions are also reported (all ≤ 0.2%). The closest radius included in the fit is specified
and varies between 0.03 and 0.2 cm. It varies since the very closest points sometimes ruin
the entire fit and/or are inside the source.
Results from extrapolating gL(r) values at larger radial distances from 10 to 15 cm using
the above fitting coefficients agreed well with MC results from egs brachy simulations in
a larger water phantom (40 cm height and 20 cm radius) for a representative source for
each isotope (mean differences in g(r) values ≤ 0.7% for 10 < r ≤ 15 cm). Changes in
gL(r ≤ 10 cm) and F (r ≤ 10 cm, θ) values were insignificant (≤ 0.1%) when we performed
calculation in the larger 40 cm phantom rather than the standard 30 cm phantom.
The 2D anisotropy function, F (r, θ), describes the variation in dose distribution in po-
lar angle due to photon scattering and attenuation, as well as self-absorption and oblique
filtration in source encapsulation. F (r, θ) values are calculated using the line source ap-
proximation and tabulated at radii of 0.1, 0.15, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, 7.5 and 10 cm
and at 32 polar angles with a minimum resolution of 5◦. For some sources (e.g., 103Pd Ci-
vaThin sources, and 125I model 9011) with smaller diameters (∼ 0.03 cm) than conventional
brachytherapy sources, values at radii such as 0.05 or 0.07 cm are included.
The 1D anisotropy function (anisotropy factor), φan(r),
3 is defined as the ratio of the
solid-angle-weighted dose-rate averaged over 4pi steradians, to the dose-rate at the same r
distance on the transverse plane. These values are calculated by integrating the solid angle
weighted dose-rate over 0◦ ≤ θ ≤ 90◦. The φan(r) factor is used in treatment planning when
the source orientation is being ignored.
II.D. Data additional to TG-43 parameters
In addition to TG-43 parameters, the database provides along and away dose-rate per air-
kerma strength data (cGy h−1 U−1), mean photon energy (E¯γ; keV) for all LDR sources, as
well as primary and scatter-separated (PSS) dose data for several sources.
Along and away dose-rate data in Cartesian coordinate are normalized to SK , air-kerma
strength, and are tabulated at 12 away distances from 0 to 10 cm and 13 along points from
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0 to 10 cm. The along and away tables can be used as part of the needed quality assurance
checks while commissioning a specific source in a brachytherapy treatment planning system.7
PSS data31 are provided for the following representative sources: 103Pd TheraSeed 200,
125I 6711 and 130.002 models, and Isoray 131Cs Rev2 model. The data are tabulated at 24
radii from 0.10 to 10 cm and 24 polar angles with a minimum resolution of 5◦. High resolution
(∆ r = 1 mm, ∆θ = 1◦) PSS data are also provided. For the purposes of these calculations,
scatter within the source is not considered as scatter so that any photon escaping the source
encapsulation is considered a primary. Doses are normalized to the total photon energy
escaping the encapsulation.
Photon energy spectra for each LDR source model are calculated using egs brachy’s
surface count scoring option. These were calculated in a water phantom with the egs brachy
spectrum-scoring routines ignoring photons scattered back across the surface from the water
and so effectively are the spectra in vacuum. Although these back-scattered photons do
have a small effect on the spectrum they have no effect on the spectrum’s mean energy. The
mean photon energy, E¯γ, for each source is in column 1 of Tables 1 and 2. The statistical
uncertainty on the mean energy is less than 0.01%. Representative photon energy spectra
for the 103Pd TheraSeed 200, 125I OncoSeed 6711, and 131Cs Cs-1 Rev2 sources are presented
on the main page of the CLRPv2 database.
II.E. Data validation
Data are validated by comparisons to previously published measurements and calculations
with other MC codes. DRC values are compared primarily to BrachyDose results from
Rodriguez and Rogers9,21 or from Taylor and Rogers,10 as well as values from other codes
and sources in the literature - see Tables 1 and 2. These comparisons give percent differences
as:
%∆(Λ1,Λ2) =
Λ1 − Λ2
Λ1
× 100%. (8)
DRC values separated by radionuclide are shown in Figure 4. Due to the large amount of
data, detailed comparisons of g(r) and F (r, θ) are omitted here, but the comparisons are
available in the database along with further DRC comparisons when available.
In general, the CLRPv2 DRC values show excellent agreement with the BrachyDose
results which modelled the same geometry with a maximum difference of 0.6% from the
data of Rodriguez and Rogers9 and/or Taylor and Rogers.10 This excludes the differences
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due to changes in how the source geometry was modelled as discussed below. The average
difference is (+0.17 ± 0.26)% for 125I sources and (−0.24 ± 0.17)% for 103Pd sources which
is excellent agreement given the statistical uncertainty of 0.3% on the earlier BrachyDose
results.
The mean DRC value for most 103Pd sources is 0.664 (cGy h−1 U−1) with a sample
standard deviation of 0.017. The exceptions are the plastic encapsulated CivaTech source
families of CivaString (CS10–CS50) and CivaThin (CT10–CT50) with values ranging from
0.624 to 0.277 (Table 1 and Figure 4). As the source length is increased from 1 cm (CS10
or CT10 sources) to 5 cm (CS50 or CT50 sources), the DRC values decrease. This is due to
the increase in the average photon pathlength from the source to the reference point on the
axis at 1 cm and hence the increased attenuation in the water phantom.
The corresponding mean DRC value for all 125I sources is 0.943 (cGy h−1 U−1) with a
sample standard deviation of 0.037 (Table 2). The DRC value for the 131Cs Rev2 source is
1.06 and larger than the average values for 103Pd and 125I due its to relatively higher-energy
spectrum, which leads to less photon attenuation in the water phantom. The mean photon
energies calculated for all 103Pd, 125I, and 131Cs sources are 20.55, 27.68, and 30.29 keV
respectively (Tables 1 and 2, column 1).
For all 125I source models containing a silver marker (indicated by a superscript ‘a’ in
Table 2), the average DRC is 0.929 cGy h−1 U−1 which is about 3.5% lower than the average
DRC of 0.962 cGy h−1 U−1 for sources without a silver marker. This is due to the lower-
energy (22, 25 keV) characteristic x rays from silver9,21,32–34 which reduce the average energy
of the spectrum from the source. The mean energy of 125I sources with a silver marker is
27.35 keV which is 0.8 keV lower than the average energy of 28.14 keV from sources without
a silver marker (Table 2, column 1). The IPlant 3500 with a silver marker (source 9) is an
outlier, with a higher DRC value of 0.982 cGy h−1 U−1. This is because the radioactive
material is not directly distributed on the silver marker’s surface,35 leading to a higher mean
photon energy and DRC value. The silver marker in 103Pd sources has virtually no effect since
the initial 103Pd photons do not excite the silver x rays. In Figure 4, those 125I sources with
DRCs ≥ 0.99 are silver-free but not all silver-free sources have higher DRCs (i.e., sources
15, 19, 21 and 22). The BT-125-1 model (source 15) has a palladium marker and the LS-1
model (source 19) has a platinum/iridium marker. These high-Z markers mainly generate
x-ray spectral components similar to sources containing a silver marker.34 The spectra of
S18 sources36 (sources 21 and 22) have a small number of low-energy x rays (10 to 15 keV)
CLRPv2 TG-43 low-energy database page 13
due to the composition of their lead-glass marker. There are not enough low-energy x rays
to significantly decrease the average energy of the spectrum. However they do increase the
air-kerma strength (due to the large mass energy absorption coefficient of air at these lower
energies) but do not affect the dose at the reference point since they are attenuated in the
water. Together these effects result in a lower DRC value.
There are some sources that show a significant DRC discrepancy when comparing
egs brachy and earlier BrachyDose values.9,10,21 These are denoted by a superscript ’f’
in Tables 1 and 2. For these four sources, the original BrachyDose air-kerma calculations
mistakenly included a thin cylindrical shell of water around the sources which decreased
the air-kerma strength and hence increased the DRC values. After the source geometries
were fixed the mean DRC value deviations between BrachyDose and egs brachy values is
reduced to <0.1% with differences ranging from -0.6% to 0.4%. A source with different ge-
ometry models in egs brachy and BrachyDose (source 13, Table 2) is omitted from these
differences.
Sources for which no BrachyDose results are available have DRCs which are within the
statistical uncertainties of other published values.
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Table 1: Dose-rate constant values for 103Pd and 131Cs sources calculated using egs brachy
(‘This work’), BrachyDose (‘RR’ and ‘TR’),9,10 other codes (‘Other MC’), and TG-43 con-
sensus data3,5, 6 (TG43con). The egs brachy and BrachyDose DRC values shown are for the
NIST WAFAC geometry. Statistical uncertainties are ≤0.3% (BD), ≤0.02% (eb), and otherwise
shown in brackets (uncertainty in the last digit). Percent differences are given between results
for egs brachy and the best BrachyDose geometry [%∆(eb,BD)], as well as with TG43con
[%∆ (eb,TG43con)]. The mean emitted photon energy (E¯γ) of each source determined by
egs brachy is indicated.
Dose-rate constant Λ (cGy h−1 U−1)
Source model (E¯γ/keV) This RR9 TR10 %∆ Other TG-43con %∆
work(eb) BD BD (eb,BD) MC (eb,TG43con)
103Pd
1 IAPd-103Aa (20.51) 0.659 0.661 0.687f -0.3 0.69(3)37 0.693(31)6 -5.2
2 Med3633a (20.50) 0.663b 0.665g 0.650 -0.3 0.67238 0.6883 -3.8
3 BT-103-3a (20.50) 0.667 0.668e 0.671 0.1 0.659(5)39 n/a n/a
4 TheraSeed 200c,i (20.51) 0.684 0.685g 0.694 -0.1 0.691(20)40 0.6863 -0.3
5 TheraSeed 200d,i (20.55) 0.689 n/a n/a n/a 0.694(20)40 n/a n/a
6 BestPd-103 2335 (20.54) 0.654b 0.654 0.650 0.0 0.67(20)41 0.6855 -4.7
7 BrachySeed Pd-1 (20.55) 0.626 0.627 0.632h -0.2 0.65(20)42 n/a n/a
8 BEBIG Pd-103 (20.50) 0.666b 0.670e 0.685f -0.60 0.660(17)43 n/a n/a
9 1031Li (20.47) 0.662b 0.663 0.663 -0.1 0.70(20)44 0.701(20)6 -5.9
10 1032Pi (20.54) 0.667b 0.669j 0.669 -0.3 0.665(21)45 0.671(19)6 -0.6
11 CivaString CS10 (20.59) 0.624 n/a n/a n/a 0.623(8)46 0.641(17)6 -2.7
0.622(9)47
12 CivaString CS20 (20.58) 0.512 n/a n/a n/a 0.510(7)46 n/a n/a
13 CivaString CS40 (20.59) 0.333 n/a n/a n/a 0.330(4)46 n/a n/a
14 CivaString CS50 (20.58) 0.279 n/a n/a n/a 0.274(4)46 n/a n/a
15 CivaThin CT10 (20.58) 0.620 n/a n/a n/a 0.619(8)46 n/a n/a
16 CivaThin CT20 (20.58) 0.509 n/a n/a n/a 0.507(7)46 n/a n/a
17 CivaThin CT40 (20.58) 0.331 n/a n/a n/a 0.328(4)46 n/a n/a
18 CivaThin CT50 (20.58) 0.277 n/a n/a n/a 0.272(4)46 n/a n/a
131Cs
19 CS-1 Rev2 (30.29) 1.063 n/a n/a n/a 1.046(19)48 1.056(13)6 0.7
1.052(26)49
a
Sources which include silver marker
b There is a change in the model of the source described in the database
c 103Pd Theragenics ‘Light seed’: thickness of Pd radioactive coating layer on graphite surface is 2.2 µm
d 103Pd Theragenics ‘Heavy seed’: thickness of Pd radioactive coating layer on graphite surface is 10.5 µm
e BrachyDose values recalculated for this work after correcting the geometry
f BrachyDose values differ from egs brachy values because of water envelope geometry known to be the cause of change
g There were some geometry changes reported in RR9 but the exact difference is unknown since the TR10 geometry file is lost
h There is an unexplained change since we do not have the MC input file of TR10
i Considering air and water in the central ‘empty’ region of the source, there is a negligible difference (0.05%) in DRC
j This value is taken from ref. RR21
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Table 2: Same as Table 1, except for 125I sources.
Dose-rate constant Λ (cGy h−1 U−1)
Source model (E¯γ/keV) This RR9 TR10 %∆ Other TG-43con %∆
work(eb) BD BD (eb,BD) MC (eb,TG43con)
1 OncoSeed 6711a (27.34) 0.932b 0.928 0.924 0.4 0.942(17)50 0.9653 -3.5
2 ThinSeed 9011a (27.26) 0.929 0.930 n/a -0.1 0.923(4)51 0.933(28)6 -0.4
3 EchoSeed 6733a,c (27.24) 0.935 0.934 n/a 0.1 0.97(3)52 0.9805 -4.8
4 EchoSeed 6733a,d (27.29) 0.927 n/a 0.929 -0.2 0.97(3)52 n/a
5 Braquibaca (27.42) 0.917 n/a 0.917 0.0 0.937(4)53 n/a n/a
6 I25.S17a (27.28) 0.917 0.915 0.916 0.1 0.914(14)54 0.933(25)6 -1.7
7 I25.S17plusa (27.30) 0.923 n/a n/a n/a 0.925(19)55 0.940(25)6 -1.8
8 IS-12501a (27.19) 0.921b 0.924 0.924 -0.3 0.9256 0.9403 -2.1
9 IPlant 3500a,l (28.30) 0.982b 0.987e 0.994f -0.5 1.017(5)35 1.0145 -3.3
10 IAI-125Aa (27.27) 0.925b 0.925 0.925 0.0 0.98(3)57 0.9815 -6.1
11 125SLa (27.17) 0.934 0.931 0.93 0.3 0.93(4)58 0.9535 -2.0
12 130.002a (27.23) 0.921 0.917 0.917 0.4 0.954(5)59 0.954(43)6 -3.6
13 AgX100
a
(27.29) 0.923 0.900
h
n/a 2.5 0.918(20)60 0.952(43)6 -2.5
14 BT-125-2a (27.35) 0.918b na 0.916 0.2 0.962(5)61 n/a n/a
15 BT-125-1 (27.28) 0.904b 0.906 0.901 -0.2 0.95(3)62 n/a n/a
16 OncoSeed 6702 (28.36) 1.010 1.007 1.000 0.3 1.00963 1.0363 -2.6
17 STM1251 (28.44) 0.992b 0.992g 1.012 0.0 0.98(2.4)64 1.0185 -2.6
18 Best 2301 (28.39) 1.001 0.999 0.998 0.2 1.01(3)65 1.0183 -1.7
19 LS-1 (27.83) 0.925 0.922 0.922 0.3 0.935(17)66 0.9725 -5.1
20 I25.S06 (.S16) (28.16) 1.003b 1.004e 1.011f -0.1 1.00267 1.0123 -0.9
21 BEBIG I25.S18j (28.17) 0.907 n/a n/a n/a 0.905(27)36 0.893(32)6 1.5
22 BEBIG I25.S18k (28.12) 0.887 n/a n/a n/a 0.905(27)36 n/a n/a
23 1251Li (28.32) 0.994 0.991 0.992 0.2 1.01(3)68 1.0385 -4.4
24 Med3631 (28.36) 0.995 0.995h 0.978 0.0 1.01(3)69 1.0363 -4.1
a
Sources which include silver marker.
b There is a change in the model of the source described in the database
c 125I coating layer in EchoSeed 6733 is assumed to have a thickness of 10 µm on surface of silver marker
d 125I coating layer in EchoSeed 6733 is assumed to have a thickness of 2 µm on surface of silver marker
e BrachyDose values recalculated for this work after correcting the geometry
f BrachyDose values differ from egs brachy values due to water envelope geometry causing the change
gThere were some geometry changes in RR9 but the original TR10 geometry coding is lost.
h There is an unexplained change since we do not have the MC input file of RR9
i Considering air and water in hole portion of the source, there is a negligible difference (0.05%) in DRC
j with minimum available %18 Lead-glass (PbO) as a marker in Bebig I25.S18 source
k with maximum available %32 Lead-glass (PbO) as a marker in Bebig I25.S18 source
l Radioactive material in IPlant3500 source is far away from silver marker, which causes a higher mean energy and also DRC value
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Figure 4: Values of DRC for different sources separated by radionuclide: 103Pd (red
circles); 125I without silver marker (blue squares) or with silver marker (pink diamonds);
and 131Cs (green triangle). CLRPv2 values calculated with egs brachy are closed sym-
bols which can appear open if the BrachyDose values overlap almost exactly. Values
calculated with BrachyDose are open symbols from refs.9,10,21 DRCs from other MC
codes with their uncertainty are also shown (x symbol). The statistical uncertainties
on egs brachy and BrachyDose values are smaller than their symbols. The x-axis
source numbers are in Tables 1 and 2.
As mentioned above, the TG-43 consensus DRC values for low-energy brachytherapy
sources have been determined by taking an average of the average of MC calculations results
and the average of the experimental measurements. Figure 5 plots the data listed in the
last column in Tables 1 and 2. It shows that the Monte Carlo DRC values are generally
lower than consensus values. This is primarily due to errors in the measured DRCs caused by
ignoring the intrinsic energy dependence of TLD detectors and the generally large systematic
uncertainties in the measurements.9 The mean (range) differences between CLRPv2 and TG-
43con DRC values for
103Pd, 125I, and 131Cs sources are -3.3% (-6%, -0.3%), -2.7% (-6.1%,
1.5%), and 0.7%, respectively. As suggested before,9 this indicates there is a need to revise
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many of the consensus values of DRCs for LDR sources and possibly to base these solely on
the Monte Carlo calculated values.
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Figure 5: Distribution of DRC percentage differences between egs brachy and TG43
consensus values as defined by equation 8 for 103Pd (red shorter dashed histogram),
125I (black solid histogram), and 131Cs (blue longer dashed histogram) sources. Values
are taken from last column in Tables 1 and 2.
In general, gL(r) values are in agreement with BrachyDose results within statistical
uncertainties for all sources studied, except for some regions very close to the source where
differences outside statistical uncertainties and up to 3% were found. This is because the
statistical uncertainties in the source volume correction needed for small r values were not
accounted for in the BrachyDose calculations.
Figure 6 presents gL(r) values as a function of r for all the sources. For sources of the same
radionuclide, gL(r >1 cm) values are nearly indistinguishable except for differences between
silver-marker and silver-free 125I sources, for the same reasons outlined in section II.E..
For r ≤ 1 cm, as discussed previously30 the behaviour is quite different depending on
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whether they are a class A source (two or more sources of radiation separated by a radio-
opaque marker) or a class B source (radioactive material distributed along the length of
the source including at the center). For class A sources, there is a dose build-up along the
transverse source axis (103Pd CS(CT)10, CS(CT)50, Pd-1, and 125I LS-1, 3631 sources in
Figure 6) because there is no radioactivity on the transverse axis. This, in turn, causes the
dose to be low very close to the source. For class B sources (103Pd CS(CT)20, CS(CT)40,
Pd-103, and all 125I sources with a silver marker in Figure 6) gL(r <1 cm) values are roughly
flat, with a slight upturn at the smallest r values, except for the much longer CivaTech
sources. In class B sources, the radioactivity is uniformly distributed and very close to
the source. In this case the simple geometry factor, GL(r, θ), breaks down and only the
radioactivity directly on the axis matters, thus attenuation in the walls of the source has a
relatively smaller impact.
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Figure 6: Radial dose function, gL(r), of all 40 sources including 17
103Pd (black dashed
lines), 22 125I (blue dashed lines with silver marker and purple solid line without silver),
and 1 131Cs (green thick dashed line) sources for CLRPv2 database as a function of
distance and radionuclide. The gL(r ≤ 1 cm) values show quite different behaviours
with a dose build-up region for class A sources (e.g., 103Pd CS(CT)10, CS(CT)50, Pd-1,
and 125I LS-1, 3631), and a flatter region with an upturn for the smallest r for class B
sources (e.g., 103Pd CS(CT)20, CS(CT)40, Pd-103, and all 125I with a silver marker).
Plots in the database of F (r, θ) for each source show that most 2D anisotropy function
values agree within statistical uncertainties with those calculated using BrachyDose. There
are a few exceptions. For all CLRPv2 LDR sources, the anisotropy functions for regions
very close to the source show differences vs CLRPv1, up to 46% due to unspecified and
presumably large statistical uncertainties in the source volume correction used with CLRPv1.
The CLRPv2 values include this uncertainty and are thus more reliable (see the effects in
Figure 2c). There are other differences which are traceable to changes in the geometric
models of the seeds and these changes are specified in the database.
Figure 7 presents F (1.0, θ) values for all the sources in the database. Generally it is
seen that the end caps attenuate the doses near 0 degrees. Sources with beads at either
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end separated by a marker (e.g., Pd-1 and Ls-1 sources) maintain anisotropy values close to
unity even close to 0 degrees. The long CivaTech sources can have very high values at 5 to
10 degrees because those points are close to the radioactivity in the longer sources.
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Figure 7: The 2D anisotropy function, F (1.0 cm, θ), of all 40 sources (17 103Pd, 22
125I, and 1 131Cs ) in the CLRPv2 database as a function of radionuclides and angle
(degrees). The F (1.0 cm, θ ≤ 20o) variations for 103Pd sources (black dashed lines)
are more significant than those for 125I sources with silver marker (blue dash-dot lines)
or without silver marker (purple solid lines), and the 131Cs source (green thick dashed
line).
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Some brachytherapy treatment planning systems use a 1D dosimetry formalism by replac-
ing the 2D anisotropy function in Equation 6, F(r, θ), with a 1D anisotropy factor, φan(r).
3
Values of φan(r) for each source are included in the database and are shown in Figure 8.
Values of φan(r) varied between 0.85 and 1.0 for r > 1 cm, except for the longer CivaTech
sources where the low value of the DRC, and hence dose at the reference position (1 cm,
90◦), led to higher values at larger distances due to source length.
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Figure 8: The 1D anisotropy function, φan(r), of all 40 sources including 17
103Pd
(black dashed lines), 22 125I (blue dash-dot lines with silver marker and purple solid
lines without silver), and 1 131Cs (green thick dashed line), as a function of distance.
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III. Data Format and Access
The CLRPv2 TG-43 parameter database is available online at https://physics.carleton.
ca/clrp/egs_brachy/seed_database_v2 with a digital objectidentifier (DOI) at http://
doi.org/10.22215/clrp/tg43v2. The website is hosted by Carleton University, in Ottawa,
Canada. The main page of the database lists all sources for which datasets are available,
information on the radionuclide source spectra and the half-lives used, and information about
spectrum average energies.
The CLRPv2 TG-43 database for low-energy LDR brachytherapy sources contains
roughly 315 data tables and 235 figures which include approximately 65,000 data points.
These datasets include available and discontinued source models (for retrospective analysis).
For each source model, the following information is available in the CLRPv2 database:
• A to-scale image showing a longitudinal cross-section of the source model created using
an egs view image of the actual egs++ model of the source.
• A description of the source’s geometric model according to the literature and manu-
facturer information, as implemented in egs++. These models will be released for use
with the open-source egs brachy application.
• A table of DRC values, with absolute uncertainties, both in units of cGy h−1 U−1,
along with values calculated with BrachyDose,9,10,21 as well as other measured and
calculated values from different publications.
• A figure comparing gL(r) data with corresponding values from Taylor and Rogers10,11
and from other papers in the literature.
• A table of fitting coefficients for gL(r) using the Taylor and Rogers modified polynomial
function.30 Extrapolating the gL(r) values using the current fitting coefficients was
validated for larger distances (10 cm≤ r ≤ 15 cm) with average differences of < 0.7%
from values based on MC simulations in a larger phantom (40 cm height and diameter).
• A figure comparing F (r, θ) data at various values of r with data from Taylor and
Rogers10,11 and from other papers in the literature.
• Tabulated along-away dose data (normalized to the air-kerma strength).
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• Low resolution PSS (primary-scatter separated) tabulated data for 103Pd TheraSeed
200, 125I 6711 and 130.002, and 131Cs Rev2 models, along with plots of representative
PSS data for these sources at different angles and radial distances. High resolution
PSS data files for these sources are also provided in CSV (comma-separated values)
format.
• A complete set of tabulated data for each individual source (DRC, g(r) and fitting
coefficients, F (r, θ), and along and away tables) in Microsoft Excel .xlsx format.
IV. Potential Impact
Despite growing momentum towards adoption of model-based dose calculation algorithms
(MBDCAs),70 clinical brachytherapy dose prescriptions remain, for the time being, based
on the AAPM TG-43 dose calculation formalism.1,3–8 Given that the vast majority of the
TG-43 DRC consensus values are underestimated (on average by 3%), the more accurate
MC-calculated datasets may, in future, be used directly. The CLRPv2 data may be used for
research related to TG-43 dosimetry and brachytherapy planning, and may be considered
in future updates to the TG-43 consensus data. Additional brachytherapy sources may be
added to the database in the future, as new source models are released. A few typos and
inaccuracies in the source geometry descriptions on the CLRPv1 database have also been cor-
rected in the v2 database. Those corrections are noted in the text on the database. Finally,
the complete brachytherapy source geometry models described in the CLRPv2 database will
be released for use with the egs brachy EGSnrc application. Release of all benchmarked
source models will enable egs brachy’s use for patient-specific model-based dose calcula-
tions, thus supporting further research and clinical adoption of MBDCAs as recommended
by AAPM-ESTRO-ABG TG-186.70
V. Conclusion
This database provides an update to the CLRP TG-43 dosimetry parameters (CLRPv2) us-
ing the EGSnrc egs brachy application for 40 low-energy photon-emitting LDR brachyther-
apy sources (22 125I, 17 103Pd, and 1 131Cs ), as well as source models to be distributed with
egs brachy. Overall, the results are in good agreement with the previous CLRP TG-43
database (CLRPv1) which used the BrachyDose application to extract the TG-43 parame-
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ters for 18 125I and 9 103Pd sources. Statistical uncertainties, source volume corrections, and
modelling of several source geometries are all improved in comparison to CLRPv1 calcula-
tions. The 22 125I sources are categorized into two groups: with and without silver marker.
The general trends show clearly that 125I sources with silver markers have lower DRC values
than those without. This is due to the contribution of lower-energy silver x rays which reduce
the mean energy of the source spectrum. With a silver marker, the mean DRC value is 0.929
with a sample deviation of ± 0.016 cGy h−1 U−1 and for silver-free 125I sources the mean
DRC is 0.962 ± 0.049 cGy h−1 U−1. For 103Pd sources, the mean DRC value is 0.664 ± 0.017
cGy h−1 U−1 except for the plastic encapsulated CivaString and CivaThin source families.
The DRC value for the 131Cs source is larger (1.06 cGy h−1 U−1) due to the relatively high-
energy spectrum compared to the other two radionuclides. More details of other TG-43 pa-
rameters are extensively presented in the CLRPv2 database which is hosted at Carleton Uni-
versity website (https://physics.carleton.ca/clrp/egs_brachy/seed_database_v2).
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